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Background: Drugs of abuse have a common property in mammals,
which is their ability to facilitate the release of the neurotransmitter and
neuromodulator dopamine in specific brain regions involved in reward and
motivation. This increase in synaptic dopamine levels is believed to act as a
positive reinforcer and to mediate some of the acute responses to drugs.
The mechanisms by which dopamine regulates acute drug responses and
addiction remain unknown.
Results: We present evidence that dopamine plays a role in the responses of
Drosophila to cocaine, nicotine or ethanol. We used a startle-induced negative
geotaxis assay and a locomotor tracking system to measure the effect of
psychostimulants on fly behavior. Using these assays, we show that acute
responses to cocaine and nicotine are blunted by pharmacologically induced
reductions in dopamine levels. Cocaine and nicotine showed a high degree of
synergy in their effects, which is consistent with an action through convergent
pathways. In addition, we found that dopamine is involved in the acute
locomotor-activating effect, but not the sedating effect, of ethanol. 
Conclusions: We show that in Drosophila, as in mammals, dopaminergic
pathways play a role in modulating specific behavioral responses to cocaine,
nicotine or ethanol. We therefore suggest that Drosophila can be used as a
genetically tractable model system in which to study the mechanisms underlying
behavioral responses to multiple drugs of abuse.
Background
Although psychostimulants, opiates and ethanol all have
different primary effects and modes of action in the
central nervous system (CNS), current theories suggest
that their positive reinforcing, or rewarding, properties are
mediated in part by an elevation of extracellular dopamine
in the nucleus accumbens [1–4]. The associated acute
locomotor-stimulating effects of these drugs have been
proposed to model their rewarding qualities [5]. Selective
destruction of dopaminergic neurons or pharmacological
inhibition of dopaminergic systems prevents the stimu-
latory effects of most drugs of abuse; these manipula-
tions also curtail drug self-administration [2,3]. For
example, antagonists of dopamine D1 and D2 receptors
block locomotor hyperactivity and self-administration of
cocaine in rodents [6–11]. In addition, mice carrying a
deletion of the dopamine D1 receptor or the dopamine
transporter (DAT) are hyperactive and insensitive to the
locomotor-activating effects of cocaine [12,13]. DAT
mutant mice can still be trained to self-administer
cocaine, however, and establish cocaine-conditioned
place preference [14,15]. These results suggest that
other neurotransmitter systems are also involved in the
rewarding effects of cocaine.
With its accessibility to genetic and molecular analysis,
Drosophila is an attractive model system in which to inves-
tigate the molecular mechanisms regulating behaviors
induced by drugs of abuse. Here, we show that responses
elicited by cocaine, nicotine or ethanol in flies are similar to
those observed in mammals, and that dopaminergic
systems play a role in the manifestation of these behaviors. 
Results and discussion
Behaviors induced by cocaine and nicotine
Upon exposure to volatilized free-base cocaine, adult
Drosophila demonstrated dose-dependent behavioral
responses. Low doses (50–75 µg) induced primarily
grooming and hyperactivity. Moderate doses (100–150 µg)
led to hypokinesis and stereotypic locomotion often mani-
fested as circling. High doses (200–400 µg) induced spas-
modic activity, tremor, and finally, complete loss of
movement (akinesia). These behaviors are qualitatively
very similar to those described by McClung and Hirsh [16].
Our drug responses were approximately twofold weaker,
however, that is, behaviors elicited by 200 µg cocaine in
our laboratory are similar to those described for 100 µg by
McClung and Hirsh [16]. The reasons for this discrepancy
are not clear. 
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Although the behaviors elicited were distinct at different
cocaine doses, there was substantial individual variation
among flies in a single experiment. In addition, individual
flies often displayed a diversity of behaviors during any
one-minute observation period, making unambiguous
scoring and quantitative analyses difficult. To avoid these
complications, we developed a simple climbing assay,
based on the observation that cocaine exposure interferes
with the fly’s normal propensity to negatively geotax in
response to mechanical stimulation (see Materials and
methods). Briefly, cocaine- or mock-exposed flies were
introduced into a one-foot-long narrow cylinder and
knocked to the bottom. Mock-treated flies responded by
quickly climbing to the top of the cylinder. This response
was reduced in a dose-dependent manner upon cocaine
exposure. The proportion of flies that failed to climb, thus
remaining at or near the bottom of the cylinder, was aver-
aged over three consecutive trials, providing a quantitative
and reproducible measure of the effect of the drug
(Figure 1a). The (+) isomer of cocaine, which has reduced
biologic activity in mammals [17], also showed reduced
efficacy when tested in our climbing assay (Figure 1a).
Flies recovered normal behavior within 15–20 minutes
after exposure to moderate cocaine doses.
An overlapping, but not identical set of behaviors occurred
when flies were exposed to volatilized nicotine. These
behaviors included a very rapid onset of hyperactivity and
spasmodic movements, leading to grooming, hypokinesis,
and to akinesia in the most affected individuals. Repeti-
tive locomotor behaviors were less obvious than in flies
exposed to cocaine. Nonetheless, nicotine exposure
impaired the flies’ ability to negatively geotax in a dose-
dependent manner (Figure 1b). Flies recovered quickly,
in approximately 5 minutes, after exposure to moderate
nicotine doses (~6 µg). The actions of nicotine are likely
to be CNS-specific because nicotinic acetylcholine recep-
tors in insects are confined to the nervous system, where
they appear to play a major excitatory role [18,19].
In summary, a simple startle-induced climbing assay
allowed us to measure behaviors induced by cocaine or
nicotine. The assay is quantitative, reproducible and
shows specificity, as indicated by the reduced efficacy of
(+) cocaine. It differs from direct observation of drug-
exposed flies in that flies are subjected to mechanical
stimulation in an environment conducive to negative geot-
axis. Thus, the effect of the drug is measured by its ability
to interfere with a normally robust fly behavior. 
The role of dopamine in cocaine and nicotine responses
In mammals, cocaine inhibits the reuptake of monoamin-
ergic neurotransmitters from the synaptic cleft through its
interaction with plasma membrane monoamine trans-
porters, including the transporters for dopamine (DAT),
norepinephrine and serotonin [20]. Although the direct
target of cocaine is not known in flies, a cocaine-sensitive
serotonin transporter has been characterized [21,22]; a
cocaine-sensitive dopamine transporter has not been
identified to date. 
To explore a role for dopamine in acute responses to
cocaine and nicotine, we tested flies with severely
reduced dopamine levels. This was achieved by feeding
flies 3-iodotyrosine (3IY), a competitive antagonist of tyro-
sine hydroxylase (TH) [23] (see Materials and methods).
The conversion of tyrosine to L-Dopa by TH is an oblig-
ate and rate-limiting step in the synthesis of dopamine.
Treatment with 3IY reduced global dopamine levels
approximately tenfold without affecting serotonin levels
(Table 1). Unlike mammals, Drosophila does not synthe-
size norepinephrine from dopamine [19]; therefore, 3IY
treatment should specifically deplete dopamine. A com-
plete loss of dopamine is incompatible with viability; for
example, loss-of-function mutations in the Drosophila pale
locus, which encodes TH [24], lead to embryonic lethality.
In addition, prolonged 3IY treatment of larvae [23] and
adults (our unpublished observations) causes akinesia and,
eventually, death. Thus, our behavioral assays were
carried out under conditions of partial dopamine loss, con-
ditions that permitted normal baseline behaviors. For
example, 3IY-treated flies displayed normal locomotion
and geotaxis and performed normally in mock-exposure
experiments [25] (see Materials and methods and below).
But they showed a significant reduction, approximately
35%, in their sensitivity to the effects of cocaine and nico-
tine (Figure 2a). This effect was attributable to a decrease
in dopamine levels, as L-Dopa treatment restored normal
sensitivity to 3IY-treated flies (Figure 2a) under condi-
tions that partially restored dopamine levels (Table 1).
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Figure 1
Cocaine and nicotine cause dose-dependent changes in Drosophila
geotaxis. The indicated doses of (a) cocaine and (b) nicotine were
delivered by flash-volatilization to wild-type male flies. Approximately
20 flies per assay were transferred to a vertical cylinder to quantify
negative geotaxis and startle responses. The open circles in
(a) correspond to flies exposed to (+) cocaine. The results show the
mean ± standard error (SE; n = 9–10, except for the highest and
lowest doses, where n = 3–4). 
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L-Dopa treatment alone at this dose did not affect drug
sensitivity (Figure 2a). Thus, a reduction in dopamine
levels that did not affect basal locomotion or geotaxis
resulted in diminished sensitivity to cocaine and nicotine,
suggesting that dopamine mediates some of the acute
effects of these drugs in Drosophila. 
To obtain a more detailed view of the effect of dopamine
depletion on cocaine-induced behaviors, we documented
the locomotion patterns of control and 3IY-treated flies
with a locomotor tracking system (see Materials and
methods). Groups of five flies were exposed to cocaine,
transferred to a viewing chamber, and filmed for several
minutes. The locomotion patterns of control and 3IY-
treated flies during the second and fourth minutes after
exposure are shown in Figure 3; the two time intervals
were chosen to illustrate the gradual increase in drug effect
observed during the first 5 minutes of exposure. The
response to mock-exposure (0 µg cocaine) was similar in
control and 3IY-treated flies (compare Figure 3a,b with
3g,h). Flies differed markedly in their response to cocaine,
however. Control flies exposed to 100 µg cocaine showed
reduced locomotion and some circling in the 1–2 minute
interval (Figure 3c); the effect of cocaine was stronger in
the 3–4 minute period when circling behavior was predomi-
nant (Figure 3d). Flies treated with 3IY and exposed to the
same dose of cocaine were less affected (Figure 3i,j); they
showed reduced locomotion compared with mock-treated
flies, but little circling, even in the 3–4 minute interval.
These effects are comparable to those obtained in control
flies exposed to 50 µg cocaine (data not shown). Upon
exposure to 200 µg cocaine, control flies showed spasmodic
movements (observed as zig-zag patterns of movement)
and severe hypokinesis (Figure 3e,f). In contrast, spas-
modic movements were rare in 3IY-treated flies exposed to
200 µg cocaine; these flies circled and were still quite
mobile (Figure 3k,l). To more accurately quantify the
effect of dopamine depletion on cocaine responses, we
compared the velocity of movement and the degree of
turning of control and 3IY-treated flies (see Materials and
methods). As described above, exposure to moderate
cocaine doses (100–200 µg) was associated with reduced
locomotion and increased circling (Table 2). Flies treated
with 3IY were found to move significantly faster than con-
trols upon exposure to 200 µg cocaine, a dose that strongly
reduced locomotion in control flies. The degree of circling
was significantly reduced in 3IY-treated flies compared
with controls exposed to 100 µg cocaine (Table 2).
Although it is not possible to accurately quantify the overall
effect of cocaine using the locomotor tracking system, we
estimate that 3IY-treated flies exposed to 200 µg cocaine
displayed behaviors that were similar to those induced by
100 µg cocaine in untreated flies. This approximately 50%
reduction in the effects of cocaine is comparable to the 35%
reduction measured in the climbing assay (Figure 2a).
In Drosophila, dopamine biosynthetic enzymes are
expressed not only in the nervous system but also in the epi-
dermis, where they participate in cuticle formation [26–28].
Therefore, HPLC measurements of dopamine levels in
fly extracts (Table 1) reflect the combined levels in cuticle
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Table 1
Treatment Dopamine concentration Serotonin concentration
(µg/ml) (µg/ml)
Vehicle 0.76 ± 0.05 (10) 0.40 ± 0.08 (8)
3IY (10 mg/ml) 0.08 ± 0.01 (10)* 0.40 ± 0.08 (8)
3IY (10 mg/ml) + 0.30 ± 0.04 (9)* 0.39 ± 0.08 (8)
L-Dopa (1 mg/ml)
L-Dopa (1 mg/ml) 1.46 ± 0.29 (10)* 0.37 ± 0.06 (8)
Vehicle 0.63 ± 0.02 (3) 0.28 ± 0.02 (3)
Reserpine (10 mM) 0.51 ± 0.03 (3) 0.30 ± 0.01 (3)
Reserpine (30 mM) 0.44 ± 0.02 (3)* 0.31 ± 0.01 (3)
Treatment of Drosophila with 3IY or reserpine reduces dopamine but
not serotonin levels. Twenty-five adult male flies were quick-frozen in
liquid nitrogen and homogenized in 200 µl 0.1 M perchloric acid.
Monoamine levels were measured using high pressure liquid
chromatography (HPLC), as described by Neckameyer [23]. This
procedure does not allow the quantification of local changes in
monoamine levels. We suspect that the more dramatic reduction of
dopamine in 3IY-treated flies is caused by the added depletion in the
cuticle. Values shown are the mean ± SE; numbers in parentheses
indicate the number of experiments. Asterisks denote p < 0.0015.
Figure 2
Pharmacological reductions of dopamine levels reduce the sensitivity of
Drosophila to cocaine and nicotine. (a) Adult wild-type flies were fed a
yeast/sucrose solution for 48 h either with or without 3IY (10 mg/ml)
and/or L-Dopa (1 mg/ml), as indicated. The responses to cocaine and
nicotine were measured as described in the Materials and methods.
Dopamine depletion induced by 3IY caused a significant reduction in the
sensitivity to cocaine and nicotine, which was reversed by simultaneous
administration of L-Dopa. No significant effect was produced by L-Dopa
alone. Asterisks indicate p < 0.001 (Student’s paired t-test) relative to
control, yeast/sucrose-fed flies (n = 20 and 17 for 200 µg and 400 µg
cocaine, respectively; n = 13 for 6 µg nicotine). All other comparisons
showed no significant differences. (b) Adult flies were fed the indicated
doses of reserpine mixed with yeast/sucrose for 24 h before behavioral
testing. Reserpine caused a dose-dependent reduction in cocaine
sensitivity (p < 0.003 for 30 µM reserpine, n = 12).
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and CNS. Although these data clearly established that
3IY and L-Dopa were ingested and had the predicted
consequences, they did not allow us to quantify
dopamine levels in the CNS. Unfortunately, dopamine
levels in dissected brain preparations were too low for
reliable measurement. With the purpose of reducing
dopamine transmission specifically in the nervous system,
we treated flies with reserpine. In mammals, reserpine
efficiently depletes synaptic dopamine and other
monoamines by inhibiting the vesicular monoamine trans-
porter-2 (VMAT-2), thus preventing it from concentrating
these neurotransmitters in synaptic vesicles [29]. Consis-
tent with the notion that reserpine would not affect
cuticle dopamine levels, flies treated with reserpine
showed only a small but significant reduction in global
dopamine levels, but surprisingly, no changes in global
serotonin levels (Table 1). Like 3IY-treated flies, reser-
pine-treated flies showed a dose-dependent reduction in
their response to cocaine (Figure 2b) while performing
normally in mock-exposure experiments. A maximal
reduction in sensitivity of 30% was achieved with 30 µM
reserpine; higher doses reduced fly fitness, causing an
apparent increase in cocaine sensitivity (data not shown).
These data also suggest that Drosophila have a vesicular
monoamine transporter that functions similarly to the
mammalian transporter; sequences with strong homology
to the mammalian reserpine-sensitive VMAT-2 gene
have recently been identified in the Drosophila genome
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Figure 3
Cocaine-induced locomotor patterns of control and dopamine-depleted
flies. Flies were exposed to 0, 100 or 200 µg cocaine, as indicated.
Panels (a–f) and (g–l) correspond to vehicle-treated control (– 3IY)
and 3IY-treated (+ 3IY) flies, respectively. The drug effect increased
gradually during the first 5 min after exposure; the locomotor patterns
during the second (1–2) and fourth (3–4) min are shown to illustrate
this effect. Treatment with 3IY had no obvious effect on mock-treated
flies (0 µg cocaine). The effect of cocaine was reduced in 3IY-treated
flies at all doses and times tested, however. See Table 2 for
quantification of these data.
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(our unpublished observations). Why serotonin levels are
not altered by reserpine treatment is unclear. 
In summary, we have shown that two mechanistically dis-
tinct pharmacological manipulations that reduce available
dopamine render flies more resistant to the effects of
cocaine. Whereas inhibition of dopamine biosynthesis
with 3IY is known to alter dopamine levels in both the
CNS and the cuticle [23], inhibition of the vesicular
monoamine transporter by reserpine, and the resulting
degradation of dopamine in synaptic terminals, should be
CNS-specific. This suggests that the observed behavioral
effects are caused by reduced levels of dopamine in the
CNS rather than loss in the cuticle. Furthermore, we
expect that compromised cuticle formation would, if any-
thing, increase drug sensitivity, which is not the case. The
monoamines tyramine and octopamine do not appear to
be involved in regulating cocaine sensitivity, as flies con-
taining mutations that interfere with the synthesis of
these monoamines show normal cocaine responses ([30]
and our unpublished observations). We cannot completely
exclude a role for serotonin in regulating cocaine respon-
siveness. Although we found that serotonin levels appear
normal in extracts from 3IY-treated flies (Table 1), it is
possible that amine levels vary locally. Serotonin-specific
immunohistochemical analysis of brains from 3IY-treated
adult flies also failed to reveal detectable changes,
however (data not shown). 
Synergistic effects on behavior of cocaine and nicotine 
Genetic or pharmacological manipulations that affect a
common process often display dose-dependent synergistic
interactions. Because our pharmacological depletion data
suggested that both cocaine and nicotine exert their
effects in part by modulating dopamine release, we tested
for behavioral interactions between the two drugs. Simul-
taneous co-administration of low doses of cocaine and
nicotine resulted in pronounced synergy in our behavioral
assay (Figure 4). For example, only 1% and 2% of flies
failed to climb when exposed to 1.5 µg nicotine or 50 µg
cocaine, respectively (Figure 4a); a 59% climbing failure
was achieved upon co-administration, an approximately
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Table 2
Cocaine 0 µg 100 µg 200 µg
Treatment – 3IY + 3IY p – 3IY + 3IY p – 3IY + 3IY p
Median velocity 1–2 min 10.9 (5) 10.0 (5) 0.602 4.7 (8) 3.8 (8) 1.000 2.3 (8) 6.5 (8) 0.036*
(mm/sec)
3–4 min 8.2 (5) 9.6 (5) 0.602 1.2 (8) 2.1 (8) 0.083 0.9 (8) 0.9 (8) 0.713
Median turning 1–2 min 10.6 (5) 9.8 (5) 0.754 19.9 (9) 12.5 (8) 0.009* 38.5 (7) 20.6 (8) 0.165
(°/mm) 
3–4 min 12.0 (5) 10.5 (5) 0.917 41.1 (6) 16.5 (8) 0.028 59.4 (9) 17.1 (5) 0.072
Treatment with 3IY reduces the sensitivity of flies to the locomotor-
depressing and circling-inducing effects of cocaine. The median
velocity (mm/sec) and median turning (°/mm) of flies exposed to
various doses of cocaine is shown for the second (1–2 min) and fourth
(3–4 min) minutes after exposure. Pairwise comparisons between
3IY-treated and vehicle-treated flies were carried out using the
Wilcoxon–Mann–Whitney U test. Values in parentheses indicate the
number of flies; asterisks denote statistically significant differences
(p < 0.05). All pairwise comparisons between mock- and cocaine-
treated flies showed highly significant differences (p ≤ 0.0063). 
Figure 4
Drosophila responds synergistically to
co-administration of low doses of cocaine
and nicotine. (a) The behavioral responses of
wild-type flies to the indicated low doses of
nicotine, cocaine, or both were measured in
the negative geotaxis assay, as described in
the Materials and methods (n = 9–15).
(b) This synergistic response was
significantly reduced (p < 0.001, n = 9) in
flies in which dopamine levels had been
reduced by 3IY treatment. 
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20-fold increase over an additive response. This synergy
was greatly diminished in 3IY-treated flies (Figure 4b),
which is consistent with the hypothesis that these drugs
act in part through a common dopaminergic pathway.
That the response was not completely abrogated by 3IY is
not surprising because this treatment did not fully deplete
dopamine levels. In addition, these drugs might also syn-
ergize through non-dopaminergic pathways. These experi-
ments do not establish whether cocaine and nicotine act
on the same cells in the fly’s nervous system. If cocaine
and nicotine acted completely independently, however,
their combined administration would be expected to have
additive effects. 
In mammals, cocaine inhibits dopamine reuptake into
dopaminergic terminals in the nucleus accumbens,
whereas nicotine is believed to activate acetylcholine
receptors, some of which are located presynaptically on
dopaminergic neurons that project to the nucleus accum-
bens. Consistent with a convergent action of these drugs
on nucleus accumbens dopamine regulation, cocaine and
nicotine show an additive effect on dopamine release in
the nucleus accumbens of freely moving rats [31]. In addi-
tion, self-administration of cocaine and nicotine has been
shown to activate common regions in the mesocortico-
limbic dopamine system in rats, as measured by induction
of Fos-related protein expression [32]. Whether additive
changes in dopamine levels in the nucleus accumbens
lead to synergistic effects on rodent behavior has, to our
knowledge, not been tested.
The role of dopamine in acute ethanol responses
The involvement of dopamine in acute drug responses can
also be demonstrated with ethanol. When placed in a small
chamber or in narrow tubes, flies displayed a basal level of
locomotion (Figure 5a,b; see Materials and methods). Upon
exposure to ethanol vapor, they immediately increased
their locomotor activity. After 7–10 minutes of hyperloco-
motion, the flies became gradually less coordinated and
increasingly sedated. After approximately 15 minutes, they
stopped righting themselves. Flies treated with 3IY also
showed an increase in locomotor activity upon ethanol
exposure, but this effect was significantly reduced during
the first 5 minutes of exposure (Figure 5a,b). The effect of
3IY was reversed by simultaneously feeding L-Dopa. The
duration of the locomotor-activating effects of ethanol and,
consequently, the exposure time leading to sedation was
not obviously changed by alterations in dopamine levels.
Ethanol absorption was not modified by treatment with
3IY and/or L-Dopa (Figure 5c), arguing that dopamine
depletion did not alter ethanol pharmacokinetics, but
specifically reduced the flies’ response to ethanol-induced
hyperactivity. Similarly, acute ethanol exposure increases
dopamine release and locomotor activity in rodents [33,34];
the latter can be blocked by administration of dopamine
receptor antagonists [35].
Conclusions
In summary, we have shown that upon acute exposure to
cocaine, nicotine or ethanol, Drosophila displays a series of
motor behaviors that are similar to those observed in
192 Current Biology Vol 10 No 4
Figure 5
Pharmacological reduction of dopamine levels decreases Drosophila
sensitivity to ethanol-induced hyperactivity. (a,b) Adult flies treated with
3IY and/or L-Dopa were tested for locomotor activity in the absence
and presence of ethanol vapor (see Materials and methods). The
average locomotion is shown at 1 min intervals in (a) and averaged over
5 min intervals in (b). The black bar at the bottom of (a) corresponds to
the period of ethanol exposure (from 0–20 min). Flies treated with 3IY
showed a significant reduction in ethanol-induced locomotor activation
in the first 5 min of exposure (p = 0.0012, n = 19). This reduction was
reversed by co-administration of L-Dopa: the behavior of flies fed both
3IY and L-Dopa was not different from that of the controls in this time
period. (b) Drug treatments did not alter basal locomotion measured in
narrow tubes (see Materials and methods); this method was used
because locomotion in the ethanol-exposure chambers in the absence
of ethanol was too low for proper quantification (see (a) prior to ethanol
exposure). (c) Treatment with 3IY and/or L-Dopa did not alter ethanol
absorption. The ethanol concentration was measured in extracts
prepared from flies exposed to ethanol for 10 or 20 min using an
alcohol dehydrogenase-coupled spectrophotometric assay [39].
Treatment groups in (c) are as defined in (b).
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mammals. In addition, we have presented evidence to show
that, as in mammals, dopaminergic systems are involved in
the manifestation of specific drug-induced behaviors. In
contrast to our findings that dopamine-depleted flies
showed decreased sensitivity to acute cocaine exposure, Li
et al. [36] have observed increased cocaine sensitivity in
flies in which evoked synaptic release from dopamine and
serotonin neurons had been inhibited by targeted tetanus
toxin expression. This apparent discrepancy could be
explained by the fact that Li et al. used flies in which both
dopamine and serotonin neurons were affected throughout
development, while our short-term pharmacological manip-
ulations of fully developed adult flies did not seem to target
serotonin neurons. Recent studies using dopamine receptor
antagonists in a decapitated preparation of Drosophila have
implicated dopaminergic systems in locomotion and
grooming [37] and the responses to cocaine and cocaethyl-
ene [38]. Taken together, these studies show not only that
behaviors induced by acute drug exposure are surprisingly
similar in flies and mammals, but also that at least some of
the neurotransmitter systems that mediate these behaviors
are conserved. We therefore suggest that Drosophila can be
used as a genetically tractable model system in which to
study the mechanisms underlying behavioral responses to
multiple drugs of abuse.
Materials and methods
Drosophila culture and behavioral assays
Adult male Drosophila melanogaster of the Canton-S wild-type strain
were used for all experiments. These flies were grown on cornmeal
molasses food at 25°C and 70% relative humidity. Cocaine (free base,
Sigma), (+) cocaine (NIDA) and nicotine (Sigma) solutions were pre-
pared by dissolution in ethanol (cocaine) or water (nicotine). Drugs were
delivered as described by McClung and Hirsh [16]. Flies were exposed
for 1 min, then placed into glass columns (23.5 cm long, 2.5 cm diame-
ter) lined with nylon mesh (250 microns, Monofilament Cloth). Columns
were knocked on a soft surface to force flies to the bottom. After 1 min,
flies remaining within 1 cm of the bottom were counted; this procedure
was performed three times at 1 min intervals. Mock-treated flies
responded by rapidly climbing back to the top of the column, presumably
as a response to startle and because of their normal motivation to nega-
tively geotaxis. Drug-treated flies showed reduced climbing as they per-
formed the various abnormal locomotor behaviors described in the text.
Drug-treated flies showed little or no recovery during the 3 min of the
assay. The drug effect score is the average (over 3 min) of the number of
flies that remained near the bottom and is expressed as a percentage of
the total number of flies. These scores distribute normally with respect of
the mean and were analyzed statistically using Student’s paired t-test.
Drug feeding protocols 
Pharmacological treatment with 3IY (Sigma) and L-Dopa (Sigma) was
carried out as described by Neckameyer [23]. L-Dopa and 3IY were
dissolved in an aqueous 5% sucrose, 2% yeast solution and a saturat-
ing amount (1.2 ml) was added to glass vials lined with 3 MM paper.
Newly eclosed males were kept in these vials for 40–48 h at 25°C and
90% relative humidity before drug exposure. Reserpine (Sigma) was
prepared as above and flies were treated for 24 h. Upon mock expo-
sure, flies treated with 3IY and/or L-Dopa displayed behaviors indistin-
guishable from vehicle-treated flies.
Ethanol-induced behaviors 
Adult male flies were exposed to 3IY and/or L-Dopa for 48 h as
described above. Flies were introduced, four at a time, into a
6 × 6 × 1.5 cm acrylic exposure chamber and allowed to rest for 1 min.
They were then videotaped during exposure to a constant flow of air for
5 min followed by ethanol vapor (approximately 15 mM) for 25 min, as
described previously [39]. Exposure chambers were covered with a
grid of orthogonal lines spaced 1.5 cm apart. The locomotor activity of
each individual fly was quantified manually as the number of lines
crossed in 1 min intervals. Basal locomotion without ethanol was mea-
sured in narrow perforated plastic tubes (3 mm diameter, 9 cm length)
and expressed as the number of lines (at 1 cm intervals) crossed per
minute. The flies’ wings were clipped 24 h before testing to avoid flight
during the ethanol exposure.
Locomotor tracking system
Five adult male flies were exposed to volatilized cocaine for 15 sec and
placed in a thin 3 × 4 cm observation chamber. They were videotaped
at a capture rate of 15 frames/sec beginning 30 sec after exposure.
Traces were generated using the Dynamic Image Analysis System
(Solltech Inc.). Paths joining contiguous traces were graphically repre-
sented over one minute intervals as dots (center of trace) connected by
lines (path traveled between frames). From these paths, the velocity of
movement (mm/sec) and the degree of turning or circling (°/mm) were
calculated and subjected to pair-wise statistical comparisons using the
Wilcoxon-Mann-Whitney test (velocity and turning of cocaine-exposed
flies do not distribute normally). Flies that failed to move during the
1 min period were eliminated from the calculations of turning.
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